1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for therapeutic potency of stem cells in disease management
5.1.1.2. Increasing government initiatives for stem cell therapy across the world
5.1.1.3. Extensive growth in the prevalence of chronic diseases
5.1.2. Restraints
5.1.2.1. Relatively high cost of the therapy
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in regenerative medicine
5.1.3.2. Rising research and development activities in stem cell therapy
5.1.4. Challenges
5.1.4.1. Concerns over ethical issues with stem cell therapy
5.2. Cumulative Impact of COVID-19

6. Stem Cell Therapy Market, by Cell Source
6.1. Introduction
6.2. Adipose tissue-derived MSCs (mesenchymal stem cells),
6.3. Bone marrow-derived MSCs,
6.4. Placental/umbilical cord-derived MSCs

7. Stem Cell Therapy Market, by Type
7.1. Introduction
7.2. Allogeneic Stem Cell Therapy
7.3. Autologous Stem Cell Therapy

8. Stem Cell Therapy Market, by Therapeutic Application
8.1. Introduction
8.2. Cardiovascular Diseases Surgeries
8.3. Inflammatory & Autoimmune Diseases
8.4. Musculoskeletal Disorders
8.5. Neurological Disorders
8.6. Other Therapeutic Applications
8.7. Wounds & Injuries

9. Stem Cell Therapy Market, by End-User
9.1. Introduction
9.2. Academic and Research Centers
9.3. Ambulatory Surgical Centers (ASCs)
9.4. Hospitals & Clinics

10. Americas Stem Cell Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Stem Cell Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Stem Cell Therapy Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Advanced Cell Technology, Inc.
14.2. AlloSource, Inc.
14.3. Anterogen Co., Ltd.
14.4. Bioheart Inc.
14.5. BioTime, Inc.
14.6. BrainStorm Cell Therapeutics Inc.
14.7. Celgene Corporation
14.8. Cellartis AB
14.9. CellGenix GmbH
14.10. Cellular Engineering Technologies Inc.
14.11. Gamida Cell Ltd
14.12. Gilead Sciences, Inc.
14.13. Holostem Terapie Avanzate Srl
14.14. JCR Pharmaceuticals Co., Ltd.
14.15. Lonza Group AG
14.16. Medipost Co., Ltd.
14.17. Nuvasive, Inc.
14.18. Osiris Therapeutics, Inc.
14.19. Pharmicell Co., Ltd.
14.20. Pluristem Therapeutics Inc.
14.21. PromoCell GmbH
14.22. RTI Surgical, Inc.
14.23. STEMCELL Technologies, Inc.
14.24. Takeda Pharmaceutical Company Limited
14.25. Vericel Corporation
14.26. VistaGen Therapeutics, Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL STEM CELL THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL STEM CELL THERAPY MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2027
FIGURE 6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MSCS (MESENCHYMAL STEM CELLS),, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MSCS (MESENCHYMAL STEM CELLS),, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BONE MARROW-DERIVED MSCS,, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BONE MARROW-DERIVED MSCS,, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PLACENTAL/UMBILICAL CORD-DERIVED MSCS, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PLACENTAL/UMBILICAL CORD-DERIVED MSCS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2027
FIGURE 15. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS STEM CELL THERAPY, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2020 VS 2027 (%)
FIGURE 20. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2027
FIGURE 22. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES SURGERIES, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES SURGERIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INFLAMMATORY & AUTOIMMUNE DISEASES, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INFLAMMATORY & AUTOIMMUNE DISEASES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL STEM CELL THERAPY MARKET SIZE, BY OTHER THERAPEUTIC APPLICATIONS, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL STEM CELL THERAPY MARKET SIZE, BY OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL STEM CELL THERAPY MARKET SIZE, BY WOUNDS & INJURIES, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL STEM CELL THERAPY MARKET SIZE, BY WOUNDS & INJURIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 35. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2027
FIGURE 37. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC AND RESEARCH CENTERS, 2018-2027 (USD MILLION)
FIGURE 38. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC AND RESEARCH CENTERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2027 (USD MILLION)
FIGURE 42. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 43. AMERICAS STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. ARGENTINA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. BRAZIL STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. CANADA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. MEXICO STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. UNITED STATES STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. AUSTRALIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. CHINA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. INDIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. INDONESIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. JAPAN STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. MALAYSIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. PHILIPPINES STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. SINGAPORE STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. TAIWAN STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. THAILAND STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. FRANCE STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. GERMANY STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. ITALY STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. NETHERLANDS STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. QATAR STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. RUSSIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. SPAIN STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. GLOBAL STEM CELL THERAPY MARKET: FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL STEM CELL THERAPY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL STEM CELL THERAPY MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL STEM CELL THERAPY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MSCS (MESENCHYMAL STEM CELLS),, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BONE MARROW-DERIVED MSCS,, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PLACENTAL/UMBILICAL CORD-DERIVED MSCS, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES SURGERIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INFLAMMATORY & AUTOIMMUNE DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL STEM CELL THERAPY MARKET SIZE, BY OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL STEM CELL THERAPY MARKET SIZE, BY WOUNDS & INJURIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC AND RESEARCH CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. AMERICAS STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. ARGENTINA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. BRAZIL STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. CANADA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. MEXICO STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. AUSTRALIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. CHINA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. INDIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. INDONESIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. JAPAN STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. MALAYSIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. PHILIPPINES STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. SINGAPORE STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. TAIWAN STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. THAILAND STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. FRANCE STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. GERMANY STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. ITALY STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. NETHERLANDS STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. QATAR STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. RUSSIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. SPAIN STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL STEM CELL THERAPY MARKET: SCORES
TABLE 52. GLOBAL STEM CELL THERAPY MARKET: BUSINESS STRATEGY
TABLE 53. GLOBAL STEM CELL THERAPY MARKET: PRODUCT SATISFACTION
TABLE 54. GLOBAL STEM CELL THERAPY MARKET: RANKING
TABLE 55. GLOBAL STEM CELL THERAPY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 56. GLOBAL STEM CELL THERAPY MARKET: MERGER & ACQUISITION
TABLE 57. GLOBAL STEM CELL THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 58. GLOBAL STEM CELL THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 59. GLOBAL STEM CELL THERAPY MARKET: INVESTMENT & FUNDING
TABLE 60. GLOBAL STEM CELL THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 61. GLOBAL STEM CELL THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

Advanced Cell Technology, Inc.
AlloSource, Inc.
Anterogen Co., Ltd.
Bioheart Inc.
BioTime, Inc.
BrainStorm Cell Therapeutics Inc.
Celgene Corporation
Cellartis AB
CellGenix GmbH
Cellular Engineering Technologies Inc.
Gamida Cell Ltd
Gilead Sciences, Inc.
Holostem Terapie Avanzate Srl
JCR Pharmaceuticals Co., Ltd.
Lonza Group AG
Medipost Co., Ltd.
Nuvasive, Inc.
Osiris Therapeutics, Inc.
Pharmicell Co., Ltd.
Pluristem Therapeutics Inc.
PromoCell GmbH
RTI Surgical, Inc.
STEMCELL Technologies, Inc.
Takeda Pharmaceutical Company Limited
Vericel Corporation
VistaGen Therapeutics, Inc.